全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

晚期非小细胞肺癌EGFR-TKIs治疗的耐药机制研究――挑战中蕴含新的曙光

, PP. 2031-2034

Keywords: 晚期非小细胞肺癌,EGFR-TKIs,耐药

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]  吴国明, 钱桂生. 晚期非小细胞肺癌EGFR-TKIs治疗的耐药机制研究――挑战中蕴含新的曙光[J]. 第三军医大学学报,2012,34(20):2031-2034.
[2]  邵克锐,王建春.吉西他滨与紫杉醇联合奈达铂治疗晚期非小细胞肺癌的疗效及毒性反应观察[J].第三军医大学学报,2012,34(14):1450.  Shao Kerui,Wang Jianchun.Efficiency and toxic reaction of nedaplatin combined with gemcitabine or paclitaxel in treatment of advanced non-small cell lung cancer: report of 133 cases[J].J Third Mil Med Univ,2012,34(20):1450. [2]方向,胡世莲,沈干,等.吉西他滨联合顺铂方案与多西紫杉醇联合顺铂方案治疗晚期非小细胞肺癌的系统评价[J].第三军医大学学报,2010,32(21):2347.  Fang Xiang,Hu Shilian,Shen Gan,et al.Treatment of advanced non-small cell lung cancer with gemcitabine or docetaxel in combination with cisplatin:a systematic review[J].J Third Mil Med Univ,2010,32(20):2347. [3]张岩巍,刘友如,张雪艳,等.107例经EGFR-TKIs一线治疗的非小细胞肺癌患者血肿瘤标记物水平与疗效的关系[J].第三军医大学学报,2012,34(20):2051.  Zhang Yanwei,Liu Youru,Zhang Xueyan,et al.Relationship between tumor marker levels and efficacy of EGFR-TKIs first-line treatment in non-small cell lung cancer patients[J].J Third Mil Med Univ,2012,34(20):2051.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133